Mohammad Shadab Siddiqui

12.1k total citations · 6 hit papers
151 papers, 6.1k citations indexed

About

Mohammad Shadab Siddiqui is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Mohammad Shadab Siddiqui has authored 151 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Epidemiology, 86 papers in Hepatology and 35 papers in Surgery. Recurrent topics in Mohammad Shadab Siddiqui's work include Liver Disease Diagnosis and Treatment (122 papers), Liver Disease and Transplantation (71 papers) and Diet, Metabolism, and Disease (31 papers). Mohammad Shadab Siddiqui is often cited by papers focused on Liver Disease Diagnosis and Treatment (122 papers), Liver Disease and Transplantation (71 papers) and Diet, Metabolism, and Disease (31 papers). Mohammad Shadab Siddiqui collaborates with scholars based in United States, Singapore and Hong Kong. Mohammad Shadab Siddiqui's co-authors include Arun J. Sanyal, Brent A. Neuschwander‐Tetri, Rohit Loomba, Manal F. Abdelmalek, David E. Kleiner, Mary E. Rinella, Diana Barb, Stephen H. Caldwell, Prem Puri and Velimir A. Luketic and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Mohammad Shadab Siddiqui

143 papers receiving 6.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

2023 1.2k citations Mary E. Rinella, Mohammad Shadab Siddiqui et al. Hepatology profile →
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

2018 452 citations Mohammad Shadab Siddiqui, Raj Vuppalanchi et al. Clinical Gastroenterology and Hepatology profile →
The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

2017 325 citations Prem Puri, Kalyani Daita et al. Hepatology profile →
<p>Obesity paradox in cardiovascular disease: where do we stand?</p>

2019 234 citations Mohammad Shadab Siddiqui et al. profile →
An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD

2021 166 citations Grace En Hui Lim, Ansel Shao Pin Tang et al. Clinical Gastroenterology and Hepatology profile →
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial

2025 16 citations Jasmohan S. Bajaj, Edith Gavis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohammad Shadab Siddiqui United States	37	4.8k	2.8k	1.6k	1.3k	769	151	6.1k
Kathleen E. Corey United States	44	4.8k 1.0×	2.5k 0.9×	1.9k 1.2×	1.3k 1.0×	857 1.1×	167	7.0k
James M. Paik United States	34	5.5k 1.2×	2.3k 0.8×	2.5k 1.6×	877 0.7×	937 1.2×	84	6.4k
Rubén Hernáez United States	30	4.1k 0.9×	2.5k 0.9×	1.4k 0.9×	1.0k 0.8×	540 0.7×	94	5.4k
Janus P. Ong United States	31	5.5k 1.1×	2.9k 1.0×	2.1k 1.3×	1.1k 0.8×	547 0.7×	72	6.3k
James Tonascia United States	31	3.6k 0.7×	1.4k 0.5×	1.8k 1.1×	847 0.6×	1.2k 1.5×	81	5.9k
Hannes Hagström Sweden	39	8.1k 1.7×	4.4k 1.6×	3.0k 1.9×	1.3k 1.0×	849 1.1×	186	9.3k
Mattias Ekstedt Sweden	31	7.9k 1.6×	4.0k 1.4×	3.2k 2.0×	1.1k 0.8×	786 1.0×	102	8.7k
Mark Muthiah Singapore	32	2.5k 0.5×	1.2k 0.4×	1.0k 0.7×	636 0.5×	403 0.5×	184	4.1k
Barjesh Chander Sharma India	46	5.8k 1.2×	5.2k 1.8×	727 0.5×	2.9k 2.1×	523 0.7×	159	7.5k
Nicola Villanova Italy	23	3.2k 0.7×	899 0.3×	1.8k 1.2×	781 0.6×	689 0.9×	40	4.3k

Countries citing papers authored by Mohammad Shadab Siddiqui

Since Specialization

Citations

This map shows the geographic impact of Mohammad Shadab Siddiqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Shadab Siddiqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Shadab Siddiqui more than expected).

Fields of papers citing papers by Mohammad Shadab Siddiqui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Shadab Siddiqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Shadab Siddiqui. The network helps show where Mohammad Shadab Siddiqui may publish in the future.

Co-authorship network of co-authors of Mohammad Shadab Siddiqui

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Shadab Siddiqui. A scholar is included among the top collaborators of Mohammad Shadab Siddiqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Shadab Siddiqui. Mohammad Shadab Siddiqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, George, Robert Lim, Leonard L.L. Yeo, et al.. (2025). Waitlist and Post‐Transplant Outcomes in Liver Transplantation for Alcohol‐Associated Liver Disease: An Individual Patient Data Meta‐Analysis. Alimentary Pharmacology & Therapeutics. 63(3). 330–340. 1 indexed citations

Pradhan, Sarada Prasad, et al.. (2025). Effects of CO2 and H2O saturation on physico-mechanical attributes of bituminous coal. Gas Science and Engineering. 139. 205643–205643. 2 indexed citations

Chee, Douglas, Cheng Han Ng, Karn Wijarnpreecha, et al.. (2024). Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH. Transplantation Direct. 10(7). e1642–e1642. 5 indexed citations

Miwa, Takao, Ryo Horita, Tatsunori Hanai, et al.. (2024). Usefulness of health checkup‐based indices in identifying metabolic dysfunction‐associated steatotic liver disease. JGH Open. 8(6). e13110–e13110. 7 indexed citations

Danpanichkul, Pojsakorn, Cheng Han Ng, Mark Muthiah, et al.. (2023). The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Alimentary Pharmacology & Therapeutics. 58(10). 1062–1074. 17 indexed citations

Jain, Vardhmaan, Anurag Mehta, Chang Liu, et al.. (2023). Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease. Journal of the American Heart Association. 12(24). e031230–e031230. 7 indexed citations

Lim, Wen Hui, Jie Ning Yong, Cheng Han Ng, et al.. (2023). Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US. Liver Transplantation. 29(11). 1181–1191. 2 indexed citations

Lim, Wen Hui, Caitlyn Tan, Jieling Xiao, et al.. (2023). De novo metabolic syndrome after liver transplantation: a meta-analysis on cumulative incidence, risk factors, and outcomes. Liver Transplantation. 29(4). 413–421. 7 indexed citations

Ng, Cheng Han, Mark Muthiah, Jieling Xiao, et al.. (2022). Meta‐analysis: analysis of mechanistic pathways in the treatment of non‐alcoholic steatohepatitis. Evidence from a Bayesian network meta‐analysis. Alimentary Pharmacology & Therapeutics. 55(9). 1076–1087. 20 indexed citations

10.

Chin, Yip Han, Chaoxing Lin, Gwyneth Kong, et al.. (2022). Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies. European Heart Journal - Quality of Care and Clinical Outcomes. 9(5). 511–519. 16 indexed citations

11.

Li, Wenhao, Cheng Han Ng, Jingxuan Quek, et al.. (2022). The growing prevalence of nonalcoholic fatty liver disease (NAFLD), determined by fatty liver index, amongst young adults in the United States. A 20-year experience. The HKU Scholars Hub (University of Hong Kong). 2(4). 19–19. 5 indexed citations

12.

Xiao, Jieling, Cheng Han Ng, Yip Han Chin, et al.. (2022). A Class Effect Network Meta-analysis of Lipid Modulation in Non-alcoholic Steatohepatitis for Dyslipidemia. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations

13.

Xiao, Jieling, Jie Ning Yong, Cheng Han Ng, et al.. (2021). A Meta‐Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients. Liver Transplantation. 28(4). 689–699. 14 indexed citations

14.

Ng, Cheng Han, Darren Jun Hao Tan, Jie Ning Yong, et al.. (2021). A Diagnostic Test Meta‐Analysis Evaluating Imaging‐Based and Blood Biomarker–Based Assessment Tools for Fibrosis After Liver Transplantation. Liver Transplantation. 28(4). 659–669. 9 indexed citations

15.

Patel, Samarth, Mohammad Siddiqui, Mohammad Siddiqui, et al.. (2020). Association Between Lipoprotein Particles and Atherosclerotic Events in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 19(10). 2202–2204. 16 indexed citations

16.

Connelly, Margery A., et al.. (2020). Review article: the impact of liver‐directed therapies on the atherogenic risk profile in non‐alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics. 52(4). 619–636. 7 indexed citations

17.

Bajaj, Jasmohan S., Nita H. Salzman, Chathur Acharya, et al.. (2019). Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial. Hepatology. 70(5). 1690–1703. 226 indexed citations

18.

Chalasani, Naga, Raj Vuppalanchi, Mary E. Rinella, et al.. (2018). Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease. eScholarship (California Digital Library). 1 indexed citations

19.

Sterling, Richard K., Carolyn Driscoll, Scott Matherly, et al.. (2018). Treatment of HCV in the Department of Corrections in the Era of Oral Medications. Journal of Correctional Health Care. 24(2). 127–136. 30 indexed citations

20.

Puri, Prem, Kalyani Daita, Andrew Joyce, et al.. (2017). The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology. 67(2). 534–548. 325 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact